Literature DB >> 21517236

The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.

Lou Qian Zhang1, Xin En Huang, Jun Wang, Jun Qing Shang, Jianling Bai, Fu Yin Liu, Xin Guan, Jian Nong Zhou.   

Abstract

PURPOSE: Studies of the association between the cyclin D1 (CCND1) G870A genetic polymorphism and risk of colorectal cancer (CRC) have generated conflicting results. In order to derive a more precise estimation, a meta-analysis was here performed.
MATERIALS AND METHODS: An extensive search of relevant studies was carried out as a meta-analysis of twenty studies with 5,975 cases and 8,333 controls.
RESULTS: Overall, a significantly elevated colorectal cancer risk was associated with variant allele 870A when all studies were pooled (AA vs. GG: OR = 1.23, 95%CI = 1.04-1.44; GA vs. GG: OR = 1.13, 95% CI = 1.01-1.26; dominant model: OR = 1.16, 95%CI = 1.03-1.31). In the subgroup analysis by ethnicity, significantly increased risks were detected among Caucasians (AA vs. GG: OR = 1.27, 95%CI = 1.04-1.44; and dominant model: OR = 1.17, 95%CI = 1.02-1.34). With stratification into sporadic CRC and hereditary nonpolyposis colorectal cancer (HNPCC), the former demonstrated increased cancer susceptibility (AA vs. GG: OR = 1.24, 95%CI = 1.04-1.48; dominant model: OR = 1.17, 95%CI = 1.04-1.33). However, no significant associations were found in either Asians or HNPCC patients for any genetic model.
CONCLUSION: The results suggest that the cyclin D1 870A allele is a low-penetrant risk factor for development of sporadic colorectal cancer, especially among Caucasians.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517236

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.

Authors:  Suresh Govatati; Gopi Krishna Singamsetty; Nayudu Nallabelli; Sravanthi Malempati; Pasupuleti Sreenivasa Rao; Venkata Kranthi Kumar Madamchetty; Sowdamani Govatati; Rudramadevi Kanapuram; Nagesh Narayana; Manjula Bhanoori; Kondaiah Kassetty; Varadacharyulu Nallanchakravarthula
Journal:  Tumour Biol       Date:  2014-08-22

2.  Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: A case control study.

Authors:  Saniya Nissar; Tufail Ahmad Lone; Mujeeb Zafar Banday; Roohi Rasool; Nissar A Chowdri; Fazl Q Parray; Safiya Abdullah; Aga Syed Sameer
Journal:  Oncol Lett       Date:  2013-01-03       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.